Programme

Friday, 2 November 2018

Section A (Hall Prague A+B)

08:00–08:30

    

Opening ceremony

Zavoral M., guests of honour

08:30–10:00

    

Postgraduate course 1:
New developments in the diagnosis of gastrointestinal tumours

Session chairs: Zavoral M., Kamarádová K., Seifert B.
08:30–08:44     The concept of alarming symptoms – time for a change in the early diagnosis of gastrointestinal tumours
Seifert B.
08:44–08:58     New developments in the molecular diagnosis of gastrointestinal tumours
Minárik M.
08:58–09:12     Optical diagnosis of pre-malignant and malignant gastrointestinal lesions – can it be used in clinical practice?
Suchánek Š.
09:12–09:26     Imaging techniques in the diagnosis of gastrointestinal tumours – new developments
Válek V.
09:26–09:40     The significance of tumour budding in gastrointestinal tumours
Kamarádová K.
09:40–10:00     Panel discussion
Zavoral M., Kamarádová K., Seifert B., Minárik M., Suchánek Š., Válek V.
10:00–10:15     Coffee break

10:15–10:45

  

STATE OF THE ART LECTURE

Session chair: Zavoral M.

The microbiome and colorectal cancer
Bureš J.

10:45–12:15

  

Postgraduate course 2:
New developments in the therapy of gastrointestinal tumours

Session chairs: Vítek P., Petruželka L., Ryska M.
10:45–10:59     New developments in the endoscopic therapy of gastrointestinal tumours
Falt P.
10:59–11:13     New developments in the endoscopic palliative therapy of gastrointestinal tumours
Nosek V.
11:13–11:27     Robotic-assisted surgery of gastrointestinal malignancies
Langer D.
11:27–11:41     Malignant potential in IBD patients
Örhalmi J.
11:41–11:55     New developments in the therapy of gastrointestinal cancer in the era of personalized/precision oncology
Petruželka L.
11:55–12:15     Panel discussion
Vítek P., Petruželka L., Ryska M., Falt P., Nosek V., Langer D., Orhalmi J.
12:15–13:30     Lunch

13:30–14:00

  

Poster section – presentations

Organizers: Cyrany J., Langer D.

14:00–15:30

  

Symposium 1 – Esophageal cancer diagnosis

Session chairs: Suchánek Š., Burgetová A., Vieth M.
14:00–14:30     STATE OF THE ART LECTURE
Session chair: Suchánek Š.
Esophageal cancer: issues in diagnosis and classification
Vieth M.
14:30–14:50     Endoscopic diagnosis of early squamous cell cancer
Wu Q.
14:50–15:05     The use of imaging techniques for the esophageal cancer staging
Burgetová A.
15:05–15:30     Panel discussion
Suchánek Š., Burgetová A., Vieth M., Wu Q.
15:30–15:45     Coffee break

15:45–16:15

  

STATE OF THE ART LECTURE

Session chair: Suchánek Š.

Surgery of gastric cancer
Jiafu J.

16:15–17:45

  

Symposium 2 – Esophageal cancer therapy

Session chairs: Martínek J., Lischke R., Zemanová M.
16:15–16:29     Endoscopic therapy of esophageal cancer
Vacková Z.
16:29–16:43     Oncological therapy in patients after non-curative endoscopic therapy of esophageal cancer
Vrána D.
16:43–16:57     Controversial issues in the surgical therapy of esophageal cancer
Pazdro A.
16:57–17:11     Neoadjuvant and adjuvant therapy of patients with advanced esophageal cancer
Zemanová M.
17:11–17:25     Future trends in the therapy of esophageal cancer (gene therapy, immunotherapy, personalized therapy)
Rábeková Z.
17:25–17:45     Panel discussion
Lischke R., Martínek J., Zemanová M., Vacková Z., Vrána D., Pazdro A., Rábeková Z.
17:45–18:00     Coffee break

18:00–18:30

  

Plenary session of the Society of Gastrointestinal Oncology
 
 

Section B (Hall Prague C+D)

14:00–15:30

  

Symposium 3 – Subhepatic tumors diagnosis

Session chairs: Rejchrt S., Andrašina T., Hermanová M.
14:00–14:14     Diagnosis of pancreatic cancer
Zavoral M.
14:14–14:28     Diagnosis of bile duct cancer
Urban O.
14:28–14:42     Cystic tumours of the pancreas
Repák R.
14:42–14:56     Radiological diagnosis of tumours in the subhepatic region
Andrašina T.
14:56–15:10     Cytology of the pancreatobiliary tract: a pathologist's view
Hurník P.
15:10–15:30     Panel discussion
Rejchrt S., Andrašina T., Hermanová M., Urban O., Repák R., Hurník P., Zavoral M.
15:30–15:45     Coffee break

15:45–17:15

  

Symposium 4 – Subhepatic tumors therapy

Session chairs: Ryska M., Špičák J., Petruželka L.
15:45–15:59     Optimising endoscopic palliative therapy of biliary obstruction
Špičák J.
15:59–16:13     Invasive radiology in the therapy of subhepatic malignancies
Pádr R.
16:13–16:27     A multidisciplinary team's decision-making on optimal therapy of a patient with ductal pancreatic adenocancer
Ryska M.
16:27–16:41     Surgical therapy of cystic neoplastic lesions of the pancreas
Nikov A.
16:41–16:55     Immunotherapy in the therapy of pancreatic cancer
Petruželka L.
16:55–17:15     Panel discussion
Petruželka L., Roček M., Ryska M., Špičák J., Záruba P.

17:15–17:45

  

STATE OF THE ART LECTURE

Session chair: Ryska M.

Personalized cancer medicine in pancreatic cancer: where are we today
Löhr M.
 
 

Section C (Cracow II)
12:30–14:00     Hands-on training 1
Organizers: Martínek J., Voška M.
16:30–18:00     Hands-on training 2
Organizers: Voška M., Tachecí I.
 
 
 

Saturday, 3 November 2018

Hotel restaurant Loreta

07:00–07:55

    

Breakfast with an Expert 1

Faecal occult blood tests
Kocna P.

Breakfast with an Expert 2

Multidisciplinary care of a patient with the GAPPS syndrome: collaboration involving a geneticist, a gastroenterologist, a surgeon and an oncologist –recent experience of the Masaryk Oncological Institute
Lordick F., Obermannová R.

Introduction (5 minutes)
Obermanová R.

Genetic diagnosis of GAPPS (10 minutes)
Foretová L.

Genetic predisposition to gastric cancer: diagnosis and monitoring of individuals at risk in a gastroenterological outpatient clinic (10 minutes)
Šachlová M.

Surgical management of hereditary gastric cancer and preventive surgeries in patients/mutation bearers (10 minutes)
Němec L.

Discussion
 
 

Section A (Hall Prague A+B)

06:55–07:55

  

Symposium 5 – Current approach to the therapy of stage II-III colorectal cancer

Session chairs: Krška Z., Dytrych P., Tomášek J., Kiss I.
06:55–07:05     Current surgical approach to colon cancer
Dytrych P.
07:05–07:15     Current surgical procedures for rectal cancer
Fraško R.
07:15–07:25     Adjuvant therapy of resected stage II and III COLORECTAL CANCER – indications
Kiss I.
07:25–07:35     Adjuvant therapy of resected stage II and III COLORECTAL CANCER – timing
Tomášek J.
07:35–07:55     Panel discussion
Krška Z., Dytrych P., Tomášek J., Kiss I., Fraško R.

08:00–09:30

  

Symposium 6 – Diagnosing gastric and GEJ cancer

Session chairs: Tachecí I., Švajdler M., Válek V.
08:00–08:14     Endoscopic diagnosis of precancerous gastric conditions and lesions
Falt P.
08:14–08:28     Early gastric cancer: an endoscopist's view
Tachecí I.
08:28–08:42     EUS in diagnosing gastric and GEJ cancer
Nosek V.
08:42–08:56     Familial gastric cancer
Repák R.
08:56–09:10     Pathology diagnosis of gastric cancer in the era of “next generation sequencing”
Švajdler M.
09:10–09:30     Panel discussion
Tachecí I., Švajdler M., Válek V., Falt P., Nosek V., Repák R.
09:30–10:00     Coffee break

10:00–11:30

  

Symposium 7 – Gastric and GEJ cancer therapy

Session chairs: Obermannová R., Šimša J., Tachecí I.
10:00–10:14     Endoscopic therapy of early gastric cancer
Tachecí I.
10:14–10:28     D2 lymphadenectomy for gastric cancer = “standard of care” in the Czech Republic?
Šimša J.
10:28–10:42     Radiotherapy in perioperative therapy of locally advanced gastric and GEJ adenocancer: before, after or never?
Soumarová R.
10:42–10:56     FLOT: a new standard of perioperative chemotherapy of locally advanced gastric and GEJ adenocancer
Grell P.
10:56–11:10     Does well-chosen sequential therapy prolong the overall survival of a patient with metastatic gastric cancer?
Obermannová R.
11:10–11:30     Panel discussion
Obermannová R., Šimša J., Soumarová R., Grell P., Tachecí I.

11:30–12:00

  

STATE OF THE ART LECTURE

Session chair: Obermannová R.

From “One Size Fits All Strategy” to Personalized Gastric Cancer Therapy
Lordick F.
12:00–13:00     Lunch

13:00–14:30

  

Symposium 8 – Colorectal cancer screening and diagnosis

Session chairs: Suchánek Š., Seifert B., Kocna P.
13:00–13:15     Colorectal cancer screening in the Czech Republic – new challenges
Suchánek Š., Zavoral M.
13:15–13:30     The contribution of general practitioners to the development of colorectal cancer screening
Šonka P.
13:30–13:45     Immunochemical occult blood tests
Kocna P.
13:45–14:10     Surveillance after polyp resection: new insights and recommendations
Jover R.
14:10–14:30     Panel discussion
Suchánek Š., Seifert B., Kocna P., Šonka P., Jover R.
14:30–15:00     Coffee break

15:00–15:30

  

STATE OF THE ART LECTURE

Session chair: Urban O.

Quality of Screening Colonoscopy in daily clinical practice
Kaminski M.

15:30–17:00

  

Symposium 9 – The therapy of colorectal cancer

Session chairs: Hoch J., Urban O., Kiss I.
15:30–15:44     Endoscopic therapy of colorectal cancer
Urban O.
15:44–15:58     Current surgical options for colorectal cancer therapy
Škrovina M.
15:58–16:12     Quality control in colorectal surgery
Hoch J.
16:12–16:26     Therapy strategies for metastatic colorectal cancer
Kiss I.
16:26–16:40     Harmonizing systemic and local therapy of metastatic colorectal cancer
Svoboda T.
16:40–17:00     Panel discussion
Hoch J., Urban O., Kiss I., Svoboda T.
 
 

Section B (Hall Prague C+D)

08:00–09:30

  

Symposium 10 – Diagnosis and therapy of hepatocellular cancer

Session chairs: Urbánek P., Oliverius M., Prausová J.
08:00–08:17     Hepatocellular cancer screening
Brůha R.
08:17–08:34     Hepatocellular cancer prevention
Urbánek P.
08:34–08:51     Surgical therapy of hepatocellular cancer –western or eastern concept?
Oliverius M.
08:51–09:08     Oncological therapy of hepatocellular cancer
Linke Z.
09:08–09:30     Panel discussion
Urbánek P., Oliverius M., Prausová J., Linke Z., Brůha R.
09:30–10:00     Coffee break

10:00–10:30

  

STATE OF THE ART LECTURE

Session chair: Ryska M.

Hepatocellular cancer and liver transplants
Froněk J.

10:30–12:00

  

Symposium 11 – Clinical practice guidelines (CPG)

Session chairs: Zavoral M., Ryska M.

10:30–10:35     Introducing the CPG project
Ryska M.
10:35–10:40     Clinical practice guidelines for the diagnosis and therapy of early colorectal cancer – introduction
Zavoral M.
10:40–10:49     Clinical practice guidelines for the diagnosis and therapy of early early colorectal cancer – endoscopic diagnosis
Suchánek Š.
10:49–10:58     Clinical practice guidelines for the diagnosis and therapy of early colorectal cancer – endoscopic therapy
Urban O.
10:58–11:07     Clinical practice guidelines for the diagnosis and therapy of early colorectal cancer – medical imaging examination
Válek V.
11:07–11:16     Clinical practice guidelines for the diagnosis and therapy of early colorectal cancer – surgical therapy
Hoch J.
11:16–11:25     Clinical practice guidelines for the diagnosis and therapy of early colorectal cancer – oncological therapy
Kiss I.
11:25–11:30     Clinical practice guidelines for the diagnosis and therapy of early colorectal cancer – conclusion
Zavoral M.

11:30–12:00

  

STATE OF THE ART LECTURE

Session chair: Zavoral M.

Colorectal cancer: Overcoming the toll of the most common and most avoidable gastrointestinal cancer
Brenner H.
12:00–13:00     Lunch

13:00–14:30

  

Symposium 12 – Gastrointestinal neuroendocrine tumours

Session chairs: Kopáčová M., Ryska M., Vítek P.
13:00–13:14     The benefits of endoscopy in the diagnosis of gastrointestinal neuroendocrine tumours
Kopáčová M.
13:14–13:28     The benefits of nuclear medicine in the diagnosis of gastrointestinal neuroendocrine tumours
Doležal J.
13:28–13:42     Surgical therapy of pancreatic neuroendocrine tumours
Záruba P.
13:42–13:56     Gastrointestinal neuroendocrine tumours: a pathologist's view
Dubová M.
13:56–14:10     Modalities of therapy for neuroendocrine tumours
Vítek P.
14:10–14:30     Panel discussion
Kopáčová M., Ryska M., Vítek P., Doležal J., Záruba P., Dubová M.
14:30–15:00     Coffee break

15:30–17:00

  

Symposium 13 – Gastrointestinal tumours: risk factors

Session chairs: Kamarádová K., Minárik M., Tomášek J.
15:30–15:44     The mutation background of gastrointestinal tumours: mechanisms of origin and clinical use
Minárik M.
15:44–15:58     Hereditary gastrointestinal cancer syndromes
Foretová L.
15:58–16:12     Dysplastic changes in IBD patients and the risks of COLORECTAL CANCER development
Kamarádová K.
16:12–16:26     Risk factors of primary hepatic tumours
Husová L.
16:26–16:40     EBM recommendations for the prevention of gastrointestinal tumours
Tomášek J.
16:40–17:00     Panel discussion
Kamarádová K., Minárik M., Tomášek J., Foretová L., Husová L.